NO20016187D0 - Polymorfer av krystallinske (2-benzhydryl-1- azabicyclo(2,2,2)oct-3-yl)-(5-iso-propyl-2-metoksybenzyl)-ammoniumklorid som NK-1 reseptor antagonister - Google Patents
Polymorfer av krystallinske (2-benzhydryl-1- azabicyclo(2,2,2)oct-3-yl)-(5-iso-propyl-2-metoksybenzyl)-ammoniumklorid som NK-1 reseptor antagonisterInfo
- Publication number
- NO20016187D0 NO20016187D0 NO20016187A NO20016187A NO20016187D0 NO 20016187 D0 NO20016187 D0 NO 20016187D0 NO 20016187 A NO20016187 A NO 20016187A NO 20016187 A NO20016187 A NO 20016187A NO 20016187 D0 NO20016187 D0 NO 20016187D0
- Authority
- NO
- Norway
- Prior art keywords
- benzhydryl
- azabicyclo
- polymorphs
- methoxybenzyl
- oct
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Otolaryngology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14023399P | 1999-06-22 | 1999-06-22 | |
PCT/IB2000/000756 WO2000078759A1 (en) | 1999-06-22 | 2000-06-06 | Polymorphs of crystalline (2-benzhydryl-1-azabicyclo[2,2,2]oct-3-yl)-(5-isopropyl-2-methoxybenzyl)-ammoniumchloride as nk-1 receptor antagonists |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20016187L NO20016187L (no) | 2001-12-18 |
NO20016187D0 true NO20016187D0 (no) | 2001-12-18 |
Family
ID=22490317
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20016187A NO20016187D0 (no) | 1999-06-22 | 2001-12-18 | Polymorfer av krystallinske (2-benzhydryl-1- azabicyclo(2,2,2)oct-3-yl)-(5-iso-propyl-2-metoksybenzyl)-ammoniumklorid som NK-1 reseptor antagonister |
Country Status (35)
Country | Link |
---|---|
US (1) | US6262067B1 (no) |
EP (1) | EP1187834A1 (no) |
JP (1) | JP2003502425A (no) |
KR (1) | KR20020030280A (no) |
CN (1) | CN1390216A (no) |
AP (1) | AP2001002367A0 (no) |
AR (1) | AR024411A1 (no) |
AU (1) | AU767336B2 (no) |
BG (1) | BG106205A (no) |
BR (1) | BR0011835A (no) |
CA (1) | CA2375265A1 (no) |
CO (1) | CO5190663A1 (no) |
CZ (1) | CZ20014458A3 (no) |
DZ (1) | DZ3055A1 (no) |
EA (1) | EA004264B1 (no) |
EC (1) | ECSP003538A (no) |
EE (1) | EE200100698A (no) |
HR (1) | HRP20010920A2 (no) |
HU (1) | HUP0201694A3 (no) |
IL (1) | IL146410A0 (no) |
IS (1) | IS6161A (no) |
MA (1) | MA26744A1 (no) |
MX (1) | MXPA02000033A (no) |
NO (1) | NO20016187D0 (no) |
NZ (1) | NZ515348A (no) |
OA (1) | OA11952A (no) |
PA (1) | PA8496701A1 (no) |
PE (1) | PE20010322A1 (no) |
PL (1) | PL352899A1 (no) |
SK (1) | SK18672001A3 (no) |
TN (1) | TNSN00137A1 (no) |
TR (1) | TR200103688T2 (no) |
UY (1) | UY26211A1 (no) |
WO (1) | WO2000078759A1 (no) |
ZA (1) | ZA200110387B (no) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6387925B1 (en) * | 1999-06-01 | 2002-05-14 | Pfizer Inc. | Polymorphs of a crystalline azo-bicyclo (2.2.2) oct-3-yl amine citrate and their pharmaceutical compositions |
US7683071B2 (en) * | 2000-07-26 | 2010-03-23 | Taro Pharmaceuticals Industries Ltd. | Composition and method for improved bioavailability and enhanced brain delivery of 5,5-diphenyl barbituric acid |
US6756379B2 (en) | 2001-07-26 | 2004-06-29 | Taro Pharmaceutical Industries Ltd. | Non-sedating barbiturate compounds as neuroprotective agents |
US6939873B2 (en) | 2000-07-26 | 2005-09-06 | Taro Pharmaceuticals Industries Limited | Non-sedating barbituric acid derivatives |
WO2004031191A1 (en) * | 2002-10-04 | 2004-04-15 | Merck Sharp & Dohme Limited | Azabicyclic spiroether derivatives as receptor antagonists |
CL2003002588A1 (es) * | 2002-12-11 | 2005-01-07 | Taro Pharmaceuticals Ireland L | Uso de una composicion farmaceutica que comprende acido n,n-dimetoximetildifenil barbiturico, acido n-metoximetildifenil barbiturico o acido difenil barbiturico o una sal farmaceuticamente aceptable del mismo para preparar un medicamento util en el t |
CA2572797A1 (en) * | 2004-07-02 | 2006-01-12 | Daniella Gutman | A process for preparing 1-methoxymethyl-5,5-diphenylbarbituric acid |
WO2008066704A2 (en) * | 2006-11-14 | 2008-06-05 | Taro Pharmaceuticals North America, Inc. | Method of improving bioavailability for non-sedating barbiturates |
UA102128C2 (en) * | 2008-12-05 | 2013-06-10 | Х. Луннбек А/С | Nalmefene hydrochloride dihydrate |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX18467A (es) * | 1988-11-23 | 1993-07-01 | Pfizer | Agentes terapeuticos de quinuclidinas |
JPH0733386B2 (ja) * | 1991-05-31 | 1995-04-12 | フアイザー・インコーポレイテツド | キヌクリジン誘導体 |
ES2096312T3 (es) * | 1992-11-12 | 1997-03-01 | Pfizer | Derivado de quinuclidina como antagonista de la sustancia p. |
US5393762A (en) * | 1993-06-04 | 1995-02-28 | Pfizer Inc. | Pharmaceutical agents for treatment of emesis |
-
2000
- 2000-05-04 US US09/564,528 patent/US6262067B1/en not_active Expired - Fee Related
- 2000-06-06 EP EP00929745A patent/EP1187834A1/en not_active Withdrawn
- 2000-06-06 BR BR0011835-4A patent/BR0011835A/pt not_active IP Right Cessation
- 2000-06-06 MX MXPA02000033A patent/MXPA02000033A/es unknown
- 2000-06-06 WO PCT/IB2000/000756 patent/WO2000078759A1/en not_active Application Discontinuation
- 2000-06-06 CN CN00809305A patent/CN1390216A/zh active Pending
- 2000-06-06 SK SK1867-2001A patent/SK18672001A3/sk unknown
- 2000-06-06 AP APAP/P/2001/002367A patent/AP2001002367A0/en unknown
- 2000-06-06 JP JP2001504925A patent/JP2003502425A/ja active Pending
- 2000-06-06 EE EEP200100698A patent/EE200100698A/xx unknown
- 2000-06-06 NZ NZ515348A patent/NZ515348A/en unknown
- 2000-06-06 KR KR1020017016407A patent/KR20020030280A/ko not_active Application Discontinuation
- 2000-06-06 IL IL14641000A patent/IL146410A0/xx unknown
- 2000-06-06 TR TR2001/03688T patent/TR200103688T2/xx unknown
- 2000-06-06 HU HU0201694A patent/HUP0201694A3/hu unknown
- 2000-06-06 AU AU47745/00A patent/AU767336B2/en not_active Ceased
- 2000-06-06 CA CA002375265A patent/CA2375265A1/en not_active Abandoned
- 2000-06-06 OA OA1200100314A patent/OA11952A/en unknown
- 2000-06-06 PL PL00352899A patent/PL352899A1/xx not_active Application Discontinuation
- 2000-06-06 CZ CZ20014458A patent/CZ20014458A3/cs unknown
- 2000-06-06 PA PA20008496701A patent/PA8496701A1/es unknown
- 2000-06-06 EA EA200101179A patent/EA004264B1/ru not_active IP Right Cessation
- 2000-06-13 CO CO00043885A patent/CO5190663A1/es not_active Application Discontinuation
- 2000-06-20 AR ARP000103053A patent/AR024411A1/es not_active Application Discontinuation
- 2000-06-20 PE PE2000000613A patent/PE20010322A1/es not_active Application Discontinuation
- 2000-06-20 UY UY26211A patent/UY26211A1/es not_active Application Discontinuation
- 2000-06-21 TN TNTNSN00137A patent/TNSN00137A1/fr unknown
- 2000-06-21 MA MA26007A patent/MA26744A1/fr unknown
- 2000-06-21 DZ DZ000113A patent/DZ3055A1/xx active
- 2000-06-22 EC EC2000003538A patent/ECSP003538A/es unknown
-
2001
- 2001-11-13 IS IS6161A patent/IS6161A/is unknown
- 2001-12-10 BG BG106205A patent/BG106205A/bg unknown
- 2001-12-11 HR HR20010920A patent/HRP20010920A2/hr not_active Application Discontinuation
- 2001-12-18 NO NO20016187A patent/NO20016187D0/no not_active Application Discontinuation
- 2001-12-19 ZA ZA200110387A patent/ZA200110387B/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0856001T3 (da) | Pyrimidinderivater som 5-HT2C-receptor-antagonister | |
EE200000492A (et) | Kristalsete orgaaniliste ühendite stabiilsed kindla kujuga osakesed | |
DK1224175T3 (da) | Benzodiazepinderivater som metabotropiske glutamatreceptorantagonister | |
FI970328A (fi) | Heterosykliset yhdisteet, jotka ovat käyttökelpoisia allosteerisinä effektoreina muskariinireseptoreissa | |
NO20004261D0 (no) | 2-aryletyl-(piperidin-4-ylmetyl)aminderivater som muscarin- reseptor antagonister | |
NO20016187D0 (no) | Polymorfer av krystallinske (2-benzhydryl-1- azabicyclo(2,2,2)oct-3-yl)-(5-iso-propyl-2-metoksybenzyl)-ammoniumklorid som NK-1 reseptor antagonister | |
NO20002036D0 (no) | Cyklopentenderivater nyttig som antagonister for motilinreseptoren | |
PL350234A1 (en) | Heterocyclic benzenesulphonamide compounds as bradykinine antagonists | |
NO20014356L (no) | Bifenylderivater som antagonister av neurokinin-1 reseptoren | |
NO994106D0 (no) | Oksazolidiner som 5-HT2A-antagonister | |
DK0912556T3 (da) | Indolinderivater, der er anvendelige som 5-HT-2C-receptorantagonister | |
NO20006227L (no) | Tetrahydroquiolinderivater som glycin antagonister | |
NO20015845D0 (no) | Polymorfe forbindelser av krystallinske (2-benzhydryl-1- azabicyclo(2.2.2)oct-3-yl)-(5-iso-propyl-2-metoksybenzyl)-amincitrat som NK-1 reseptor antagonister | |
AU1735200A (en) | Novel isoxazoline fibrinogen receptor antagonists | |
NO995782L (no) | Kvarternaere ammoniumforbindelser som tachykinin-antagonister | |
NO985972L (no) | Indolinderivater anvendelige som 5-HT-2C reseptorantagonister | |
DK0815105T3 (da) | Heterocyklisk substituerede piperazinonderivater som tachykininreceptor-antagonister | |
FI943359A0 (fi) | Atsasykliset-heterosykliset yhdisteet angiotensiini II reseptoriantagonisteina | |
NO943101D0 (no) | 2,6-metano-2H-kinolizinderivat som 5-HT3-reseptorantagonist | |
DK0882044T3 (da) | 1,4-dihydropyridinforbindelser som bradykinin-antagonister | |
DK1207159T3 (da) | Heteroaromatiske derivater som dopamin-D4-receptorantagonister | |
DK0994876T3 (da) | Kvaternære ammoniumforbindelser som tachykinin-antagonister | |
DK1200402T3 (da) | Substituerede 1,5-dihydropyrrol-2-on-derivater med virkning som NMDA-receptorantagonister til behandling af smertetilstande | |
AU2002354104A1 (en) | Fused bicyclic pyridine derivatives as tachykinin receptor antagonists | |
ID25461A (id) | Turunan 2-ariletil-(piperidin-4-ilmetil)amina sebagai antagonis reseptor muskarinik |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |